Translational-oncology.de
Advancing the science and practice of clinical pharmacology and translational medicine for the therapeutic benefit of patients and society.
Testing in vivo, in vitro, xenograft, orthotopic xenograft, syngeneic and cancer. EPO offers customized and comprehensive service for the preclinical ...
Join thousands of precision medicine and life science innovators at the 31st International Precision Med Tri-Conference & Expo, March 26-28, 2024, Hilton San Diego Bay Front in San Diego, CA.
TRON. Is an independent biopharmaceutical non-profit translational research organization pursuing new diagnostics and drugs for the treatment of cancer and other diseases with high medical need.
Oncothermie, Hyperthermie, Medizin 2000
Le Cancéropôle Grand Sud-Ouest (GSO) est un des sept Cancéropôles identifiés au niveau national par l'Institut National du Cancer (INCa). Dans une démarche inter-régionale et pluridisciplinaire, il a pour vocation de mobiliser contre le Cancer
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Das Nationale Centrum für Tumorerkrankungen Dresden (NCT/UCC) vereinigt Patientenversorgung, Krebsforschung und Krebsprävention unter einem Dach: Wir sagen Krebs den Kampf an!
CeGaT is a worldleader in genetic analyses for a wide range of medical, research and pharmaceutical applications.
Join the newly created Immuno-Oncology international event in Lübeck and exchange about the latest research in immuno-oncology during a comprehensive 2 days workshop. October 17-18, 2018 | Lübeck, Germany
Promotion and conduction of new, independent, clinical and translational research projects in oncology, in collaboration with Patients' Associations, Medical and Scientific Community and the Pharmaceutical Industry.
BraYn stands for
Contract Research Organization CRO of choice as your Drug Development partner working and collaborating with pharmaceutical companies
REDEFINING ANTIBODY THERAPIES